Synovial Fibroblast 1: Secretion response of primary human synovial fibroblast samples from one healthy and one rheumatoid arthritis donor to a panel of 10 stimuli and 10 small molecule inhibitors - Dataset (ID:20233)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
|---|---|---|---|---|---|---|---|---|---|---|---|
| N2586 | Lestaurtinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | MCP-1 (MCAF) | 11690.0 | 67 | |
| N2586 | Ruxolitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | MCP-1 (MCAF) | 12078.0 | 65 | |
| N2586 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | MCP-1 (MCAF) | 8793.0 | 63 | |
| N2586 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 3 | MCP-1 (MCAF) | 9449.0 | 79 | |
| RA2159 | 3 | MCP-1 (MCAF) | 2326.5 | 78 | |||||||
| RA2159 | PD184352 | 0.1 | uM | 3 | MCP-1 (MCAF) | 2076.0 | 93 | ||||
| RA2159 | Lestaurtinib | 0.3 | uM | 3 | MCP-1 (MCAF) | 2242.5 | 54 | ||||
| RA2159 | Ruxolitinib | 0.3 | uM | 3 | MCP-1 (MCAF) | 2917.0 | 71 | ||||
| RA2159 | Tofacitinib | 0.3 | uM | 3 | MCP-1 (MCAF) | 2735.0 | 63 | ||||
| RA2159 | IKK16 | 2.0 | uM | 3 | MCP-1 (MCAF) | 1279.0 | 67 | ||||
| RA2159 | 3 | MCP-1 (MCAF) | 3261.0 | 113 | |||||||
| N2586 | 3 | MCP-1 (MCAF) | 7454.0 | 61 | |||||||
| N2586 | PD184352 | 0.1 | uM | 3 | MCP-1 (MCAF) | 5893.0 | 93 | ||||
| N2586 | Lestaurtinib | 0.3 | uM | 3 | MCP-1 (MCAF) | 5057.0 | 68 | ||||
| N2586 | Ruxolitinib | 0.3 | uM | 3 | MCP-1 (MCAF) | 6445.5 | 86 | ||||
| N2586 | Tofacitinib | 0.3 | uM | 3 | MCP-1 (MCAF) | 4989.0 | 61 | ||||
| N2586 | IKK16 | 2.0 | uM | 3 | MCP-1 (MCAF) | 4267.0 | 73 | ||||
| N2586 | 3 | MCP-1 (MCAF) | 7335.0 | 67 | |||||||
| RA2159 | Visfatin | 1 | ng/mL | 3 | MCP-1 (MCAF) | 3464.0 | 91 | ||||
| RA2159 | PD184352 | 0.1 | uM | Visfatin | 1 | ng/mL | 3 | MCP-1 (MCAF) | 2178.5 | 68 | |
| RA2159 | Lestaurtinib | 0.3 | uM | Visfatin | 1 | ng/mL | 3 | MCP-1 (MCAF) | 2862.0 | 61 | |
| RA2159 | Ruxolitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 3 | MCP-1 (MCAF) | 2955.0 | 73 | |
| RA2159 | Tofacitinib | 0.3 | uM | Visfatin | 1 | ng/mL | 3 | MCP-1 (MCAF) | 2786.0 | 74 | |
| RA2159 | IKK16 | 2.0 | uM | Visfatin | 1 | ng/mL | 3 | MCP-1 (MCAF) | 1373.5 | 78 | |
| N2586 | Visfatin | 1 | ng/mL | 3 | MCP-1 (MCAF) | 7365.0 | 73 |